Orion Portfolio Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.04M | Buy |
3,857
+113
| +3% | +$30.5K | 0.01% | 1062 |
|
|
2024
Q4 | $881K | Buy |
3,744
+203
| +6% | +$47.8K | 0.01% | 1122 |
|
|
2024
Q3 | $974K | Buy |
3,541
+457
| +15% | +$126K | 0.01% | 1049 |
|
|
2024
Q2 | $749K | Buy |
3,084
+939
| +44% | +$228K | 0.01% | 1114 |
|
|
2024
Q1 | $321K | Sell |
2,145
-384
| -15% | -$57.4K | ﹤0.01% | 1436 |
|
|
2023
Q4 | $498K | Sell |
2,529
-56
| -2% | -$11K | 0.01% | 1212 |
|
|
2023
Q3 | $458K | Buy |
2,585
+229
| +10% | +$40.6K | 0.01% | 1232 |
|
|
2023
Q2 | $447K | Sell |
2,356
-128
| -5% | -$24.3K | ﹤0.01% | 1252 |
|
|
2023
Q1 | $498K | Buy |
2,484
+1,464
| +144% | +$293K | 0.01% | 1142 |
|
|
2022
Q4 | $242K | Buy |
1,020
+8
| +0.8% | +$1.9K | 0.01% | 718 |
|
|
2022
Q3 | $203K | Buy |
+1,012
| New | +$203K | 0.01% | 698 |
|
|
2020
Q3 | – | Sell |
-75
| Closed | -$11K | – | 490 |
|
|
2020
Q2 | $11K | Sell |
75
-72
| -49% | -$10.6K | ﹤0.01% | 1152 |
|
|
2020
Q1 | $16K | Buy |
147
+72
| +96% | +$7.84K | ﹤0.01% | 905 |
|
|
2019
Q4 | $9K | Buy |
+75
| New | +$9K | ﹤0.01% | 1024 |
|